Simcere Pharmaceutical Group (SCR_old)

NYSE

Currency in USD

9.60

0.00(0.00%)

Closed·23/12

Day's Range

9.59

9.60

52 wk Range

0.00

9.60

SCR_old Income Statement

Assess the Simcere income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the SCR_old net worth.

Period Ending:

2012

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

4,999.72

6,324.08

6,607.81

6,635.21

7,731.41

Total Revenues Growth

aa.aa

+10.89%

+26.49%

+4.49%

+0.41%

+16.52%

Cost Of Revenues

aa.aa

1,079.98

1,327.4

1,623.65

1,310.63

1,421.56

Gross Profit

aa.aa

3,919.74

4,996.68

4,984.15

5,324.58

6,309.86

Gross Profit Growth

aa.aa

+8.62%

+27.47%

-0.25%

+6.83%

+18.5%

Gross Profit Margin %

aa.aa

78.4%

79.01%

75.43%

80.25%

81.61%

Other Operating Expenses, Total

aa.aa

3,686.4

4,390.34

4,273.32

4,191.3

4,892.74

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+22.52%	+19.1%	-2.67%	-1.92%	+16.74%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,416.72	1,728.28	1,563.14	1,410.12	1,563.02
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,419.19	2,834.87	2,854.8	3,030.26	3,510.85
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-149.51	-172.81	-144.62	-249.08	-181.13

Operating Income

aa.aa

233.33

606.34

710.84

1,133.28

1,417.11

Operating Income Growth

aa.aa

-61.11%

+159.86%

+17.23%

+59.43%

+25.04%

EBIT Margin %

aa.aa

4.67%

9.59%

10.76%

17.08%

18.33%

Net Interest Expenses

aa.aa

-2.56

25.46

20.39

-30.33

-40.05

Net Interest Expenses Growth

aa.aa

+97.62%

+1,094.1%

-19.9%

-248.74%

-32.05%

Interest Expense, Total

aa.aa

-70.85

-34.41

-34.57

-69.56

-95.8

Interest And Investment Income

aa.aa

68.29

59.87

54.96

39.23

55.75

Other Non Operating Expenses, Total

aa.aa

71.82

-57.03

-5.44

-18.71

20.89

EBT, Excl. Unusual Items

aa.aa

302.6

574.78

725.79

1,084.24

1,397.95

Gain (Loss) On Sale Of Assets

aa.aa

402.02

-10.57

791.92

0.98

0.23

Other Unusual Items, Total

aa.aa

208.94

-32.86

0.9

-20.93

EBT, Incl. Unusual Items

aa.aa

1,401.8

886.25

740.04

819.88

1,514.33

EBT, Incl. Unusual Items Growth

aa.aa

+74.12%

-36.78%

-16.5%

+10.79%

+84.7%

EBT, Incl. Unusual Items Margin

aa.aa

28.04%

14.01%

11.2%

12.36%

19.59%

Income Tax Expense

aa.aa

-97.12

-40.48

26.09

86.71

170.32

Net Income to Company

aa.aa

1,498.92

926.73

713.95

733.17

1,344.01

Minority Interest

aa.aa

8.18

4.14

0.81

Net Income

aa.aa

1,507.1

930.87

714.76

733.17

1,344.01

Net Income Growth

aa.aa

+125.1%

-38.23%

-23.22%

+2.57%

+83.32%

Net Income Margin %

aa.aa

30.14%

14.72%

10.82%

11.05%

17.38%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

1,507.1

930.87

714.76

733.17

1,344.01

Basic EPS - Continuing Operations

aa.aa

0.58

0.36

0.27

0.29

0.54

Basic EPS - Continuing Operations Growth

aa.aa

+106.46%

-38.29%

-23.14%

+6.48%

+85.66%

Diluted EPS - Continuing Operations

aa.aa

0.58

0.36

0.27

0.29

0.54

Diluted EPS - Continuing Operations Growth

aa.aa

+106.46%

-38.29%

-24.26%

+7.41%

+86.21%

Basic Weighted Average Shares Outstanding

aa.aa

2,608.64

2,611.17

2,608.53

2,512.95

2,481.25

Diluted Weighted Average Shares Outstanding

aa.aa

2,611.36

2,620.38

2,608.53

2,519.98

2,488.56

Dividend Per Share

aa.aa

0.15

0.16

0.18

Dividend Per Share Growth

aa.aa

+6.67%

+12.5%

EBITDA

aa.aa

422.45

815.38

925.12

1,356.45

1,640.28

EBITDA Growth

aa.aa

-44.31%

+93.01%

+13.46%

+46.62%

+20.92%

EBITDA Margin %

aa.aa

8.45%

12.89%

14%

20.44%

21.22%

EBIT

aa.aa

233.33

606.34

710.84

1,133.28

1,417.11

* In Millions of CNY (except for per share items)

S&P/TSX

33,891.18

-73.15

-0.22%

S&P/TSX 60

1,977.80

-4.92

-0.25%

US 30

49,454.30

-197.6

-0.40%

US 500

7,219.80

+10.8

+0.15%

S&P 500 VIX

16.99

+0.10

+0.59%

DAX

24,292.38

+337.82

+1.41%

Dollar Index

98.01

+0.090

+0.09%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	63.88	-1.48%	9.01M
TC Energy	90.63	-0.49%	4.98M
Toronto Dominion Bank	145.84	-0.33%	4.70M
Bank of Nova Scotia	106.05	+0.35%	4.24M
Bank of Montreal	207.41	+0.28%	2.07M
RBC	244.20	-0.05%	1.51M
Fairfax Financial	2,170.28	-7.67%	168.83K

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
Vertiqal Studios	0.01	+200.00%	146.72K
Vertiqal Studios	0.01	+200.00%	146.72K
Irwin Naturals	0.30	+150.00%	3.24K
Taurus Gold	0.07	+150.00%	46.05K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.01	-75.00%	8.00K
Resource Centrix Holdings	1.50	-60.00%	600.00
Noveris Health Sciences	0.80	-57.67%	46.86K
Noveris Health Sciences	0.800	-57.67%	46.86K
Patriot Gold	0.07	-51.85%	1.00K
Armada Mercantile Ltd	0.135	-51.79%	7.00K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	17.07	+0.35%	4.16M
Air Canada	18.26	-2.09%	5.48M
Celestica Inc.	569.51	+2.12%	347.49K
Toronto Dominion Bank	145.84	-0.33%	4.70M
Canadian Natural	63.88	-1.48%	9.01M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaaaaaaaa	90.41	+62.25%	146.69
Aaaa Aaaa	3.20	+58.61%	5.08
Aaaaaa	17.39	+57.43%	27.38
Aaaa Aaaaaaaa Aa	10.120	+53.93%	15.578
A Aaa Aaaaaaaaaaaa	5.35	+52.62%	8.17
A A Aa Aaaa Aa	7.67	+52.08%	11.66
Aaaaaaa	2,441.95	+46.09%	3,567.44

Name	Last	Upside	Fair Value
A Aaaaaaaaaa	90.41	+62.25%	146.69
Aaaa Aaaa	3.20	+58.61%	5.08
Aaaaaa	17.39	+57.43%	27.38
Aaaa Aaaaaaaa Aa	10.120	+53.93%	15.578
A Aaa Aaaaaaaaaaaa	5.35	+52.62%	8.17
A A Aa Aaaa Aa	7.67	+52.08%	11.66
Aaaaaaa	2,441.95	+46.09%	3,567.44

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Simcere Pharmaceutical Group (SCR_old)

SCR_old Income Statement

Trending Stocks